CNCR stock icon

ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR

$15.82
3.67%

Market Cap: 18.7M

0
Funds holding %
of 6,702 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

24% more capital invested

Capital invested by funds: $1.7M [Q4 2023] → $2.12M (+$418K) [Q1 2024]

8% more funds holding

Funds holding: 13 [Q4 2023] → 14 (+1) [Q1 2024]

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

2.69% less ownership

Funds ownership: 12.28% [Q4 2023] → 9.6% (-2.69%) [Q1 2024]

Research analyst outlook

We haven’t received any recent analyst ratings for CNCR.

Financial journalist opinion